作者
A Gori, G Rizzardini, B Van't Land, K Ben Amor, J Van Schaik, Carlo Torti, T Quirino, C Tincati, A Bandera, J Knol, K Benlhassan-Chahour, D Trabattoni, D Bray, A Vriesema, G Welling, J Garssen, M Clerici
发表日期
2011/9/1
期刊
Mucosal immunology
卷号
4
期号
5
页码范围
554-563
出版商
Elsevier
简介
Intestinal mucosal immune system is an early target for human immunodeficiency virus type 1 (HIV-1) infection, resulting in CD4+ T-cell depletion, deterioration of gut lining, and fecal microbiota composition. We evaluated the effects of a prebiotic oligosaccharide mixture in highly active antiretroviral therapy (HAART)-naive HIV-1-infected adults. In a pilot double-blind, randomized, placebo-controlled study, 57 HAART-naive HIV-1-infected patients received a unique oligosaccharide mixture (15 or 30 g short chain galactooligosaccharides/long chain fructooligosaccharides/pectin hydrolysate-derived acidic oligosaccharides (scGOS/lcFOS/pAOS) daily) or a placebo for 12 weeks. Microbiota composition improved significantly with increased bifidobacteria, decreased Clostridium coccoides/Eubacterium rectale cluster, and decreased pathogenic Clostridium lituseburense/Clostridium histolyticum group levels upon …
引用总数
2011201220132014201520162017201820192020202120222023202431021162023252016201510158